| Bioactivity | Guacetisal is obtained from the esterification of acetylsalicylic acid with guaiacol which has the potential for chronic bronchitis treatment extracted from patent CN 106866420 A. | ||||||||||||
| Name | Guacetisal | ||||||||||||
| CAS | 55482-89-8 | ||||||||||||
| Formula | C16H14O5 | ||||||||||||
| Molar Mass | 286.28 | ||||||||||||
| Appearance | Solid | ||||||||||||
| Transport | Room temperature in continental US; may vary elsewhere. | ||||||||||||
| Storage |
|
||||||||||||
| Reference | [1]. Li, Junguang, et al. Guacetisal crystal form compound and its preparation method. CN 106866420 A. |